Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada

Abstract Background Every year, over 1 million people develop isoniazid (INH) resistant tuberculosis (TB). Yet, the optimal treatment regimen remains unclear. Given increasing prevalence, the clinical efficacy of regimens used by physicians is of interest. This study aims to examine treatment outcom...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Kamila Romanowski, Leslie Y. Chiang, David Z. Roth, Mel Krajden, Patrick Tang, Victoria J. Cook, James C. Johnston
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2017-09-01
Serie:	BMC Infectious Diseases
Soggetti:	Mycobacterium tuberculosis INH resistance Tuberculosis treatment
Accesso online:	http://link.springer.com/article/10.1186/s12879-017-2706-0
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!